Previous 10 |
home / stock / bposy / bposy news
Introduction Postal services are still encountering severe pressure in Europe as the regular mail volumes continue to decrease. The only possibility to remain 'in business' is to focus on e-commerce solutions and parcel logistics. Virtually every postal company in Europe is making this tra...
Introduction In this edition of the Nest Egg Portfolio, we will have another look at Wereldhave ( OTC:WRDEF ) whose share price remains under severe pressure despite having exited the Finnish commercial real estate market by selling its asset. The balance sheet was strengthened with the ...
Introduction After having discussed Hunter Douglas ( HDUGF ) in the previous edition of Focus on Europe, we are sticking around in the ‘Low Countries’ to look at Belgian postal service company Bpost ( BPOSF ) ( BPOSY ), which saw its share price increase by a double digit...
Introduction In this edition of the Nest Egg Portfolio, we will have another look at BT Group ( BT ) , which still seems to be under pressure. We are still waiting for the company’s full-year results, which should be out in a few months, but let’s use its 9M overview to keep...
News, Short Squeeze, Breakout and More Instantly...
Bpost S.A. / N.V ADR Company Name:
BPOSY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...